Lataa...
Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy
The identification of key driver mutations in melanoma has led to the development of targeted therapies aimed at BRAF and MEK, but responses are often limited in duration. There is growing evidence that MAPK pathway activation impairs antitumor immunity and that targeting this pathway may enhance re...
Tallennettuna:
| Julkaisussa: | Curr Oncol Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330383/ https://ncbi.nlm.nih.gov/pubmed/27215436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-016-0531-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|